Sergio Mezzano

10.9k total citations · 2 hit papers
131 papers, 6.2k citations indexed

About

Sergio Mezzano is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Sergio Mezzano has authored 131 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Nephrology, 44 papers in Molecular Biology and 34 papers in Immunology. Recurrent topics in Sergio Mezzano's work include Renal Diseases and Glomerulopathies (29 papers), Chronic Kidney Disease and Diabetes (20 papers) and Connective Tissue Growth Factor Research (15 papers). Sergio Mezzano is often cited by papers focused on Renal Diseases and Glomerulopathies (29 papers), Chronic Kidney Disease and Diabetes (20 papers) and Connective Tissue Growth Factor Research (15 papers). Sergio Mezzano collaborates with scholars based in Chile, Spain and United States. Sergio Mezzano's co-authors include Marta Ruiz‐Ortega, Jesús Egido, Leopoldo Ardiles, Vanesa Esteban, Alejandra Droguett, J. Egido, Óscar Lorenzo, Alberto Ortíz, Mónica Rupérez and M. Eugenia Burgos and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Sergio Mezzano

130 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities

2020 251 citations Lucas Opazo-Ríos, Sebastián Mas et al. International Journal of Molecular Sciences profile →
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

2020 232 citations Sandra Rayego‐Mateos, José Luis Morgado‐Pascual et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Sergio Mezzano

Since Specialization

Citations

This map shows the geographic impact of Sergio Mezzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Mezzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Mezzano more than expected).

Fields of papers citing papers by Sergio Mezzano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Mezzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Mezzano. The network helps show where Sergio Mezzano may publish in the future.

Co-authorship network of co-authors of Sergio Mezzano

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Mezzano. A scholar is included among the top collaborators of Sergio Mezzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Mezzano. Sergio Mezzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Consenso multidisciplinario sobre el uso de inhibidores de SGLT-2 (iSGLT-2) en la práctica clínica chilena mediante metodología GRADE 2024 ·Revista médica de Chile ·(unknown), (unknown), Eduardo Lorca, (unknown), Sergio Mezzano, Rodrigo Tagle, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Interleukin-17A: Potential mediator and therapeutic target in hypertension 2021 ·Nefrología (English Edition) ·Raúl R. Rodrigues-Díez, Antonio Tejera‐Muñoz, Macarena Orejudo, Laura Márquez‐Expósito, (unknown), Sandra Rayego‐Mateos, Elena Cantero‐Navarro, Lucía Tejedor-Santamaria, Vanessa Marchant, Alberto Ortíz, Jesús Egido, Sergio Mezzano, Rafael Selgas, Juan F. Navarro‐González, José Manuel Valdivielso, Carolina Lavoz, Marta Ruiz‐Ortega	14
3	Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities breakdown → 2020 ·International Journal of Molecular Sciences ·Lucas Opazo-Ríos, Sebastián Mas, Gema Marín‐Royo, Sergio Mezzano, Carmen Gómez‐Guerrero, Juan Antonio Moreno, Jesús Egido	251
4	Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy breakdown → 2020 ·International Journal of Molecular Sciences ·Sandra Rayego‐Mateos, José Luis Morgado‐Pascual, Lucas Opazo-Ríos, Melania Guerrero‐Hue, Cristina García‐Caballero, Cristina Vázquez‐Carballo, Sebastián Mas, Ana B. Sanz, Carmen Herencia, Sergio Mezzano, Carmen Gómez‐Guerrero, Juan Antonio Moreno, Jesús Egido	232
5	Lyso-Gb3 activates Notch1 in human podocytes 2015 ·Human Molecular Genetics ·María Dolores Sánchez-Niño, Daniel Carpio, Ana B. Sanz, Marta Ruiz‐Ortega, Sergio Mezzano, Alberto Ortíz	107
6	Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation 2012 ·PLoS ONE ·Carolina Lavoz, Raquel Rodrigues‐Díez, Alberto Benito‐Martín, Sandra Rayego‐Mateos, Raúl R. Rodrigues-Díez, Matilde Alique, Alberto Ortíz, Sergio Mezzano, Jesús Egido, Marta Ruiz‐Ortega	34
7	TWEAK (tumor necrosis factor–like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation 2012 ·Kidney International ·María C. Izquierdo, Ana B. Sanz, Sergio Mezzano, Julia Blanco, Susana Carrasco, María Dolores Sánchez-Niño, Alberto Benito‐Martín, Marta Ruiz‐Ortega, Jesús Egido, Alberto Ortíz	59
8	HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II 2011 ·Laboratory Investigation ·María Dolores Sánchez-Niño, Ana B. Sanz, Elsa Sánchez‐López, Marta Ruiz‐Ortega, Alberto Benito‐Martín, Moin A. Saleem, Peter W. Mathieson, Sergio Mezzano, Jesús Egido, Alberto Ortíz	55
9	Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process 2010 ·PLoS ONE ·Raúl R. Rodrigues-Díez, Raquel Rodrigues‐Díez, Carolina Lavoz, Sandra Rayego‐Mateos, Esther Civantos, Juan Rodríguez‐Vita, Sergio Mezzano, Alberto Ortíz, Jesús Egido, Marta Ruiz‐Ortega	56
10	El factor de crecimiento de tejido conectivo (CTGF): factor clave en el inicio y la progresión del daño renal 2009 ·Nefrología ·Elsa Sánchez‐López, Raúl R. Rodrigues-Díez, Juan Rodríguez‐Vita, (unknown), (unknown), (unknown), Sergio Mezzano, Rafael Selgas, Jesús Egido, Alberto Ortíz, Marta Ruiz‐Ortega	16
11	Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation 2009 ·PLoS ONE ·Vanesa Esteban, Silvia Heringer‐Walther, Anja Sterner‐Kock, (unknown), Sandra van den Engel, Yong Wang, Sergio Mezzano, Jesús Egido, Heinz‐Peter Schultheiss, Marta Ruiz‐Ortega, Thomas Walther	109
12	Co-regulation of Gremlin and Notch signalling in diabetic nephropathy 2007 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·David Walsh, Sarah Roxburgh, Paul McGettigan, Céline C. Berthier, Desmond G. Higgins, Matthias Kretzler, Clemens D. Cohen, Sergio Mezzano, Derek P. Brazil, Finian Martin	95
13	Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? 2005 ·Kidney International ·Stephen Batsford, Sergio Mezzano, Michael J. Mihatsch, Emile Schiltz, (unknown)	65
14	Introduction 2003 ·Kidney International ·Sergio Mezzano, Jesús Egido, (unknown)	1
15	Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney 2002 ·Kidney International ·Marta Ruiz‐Ortega, Mónica Rupérez, Óscar Lorenzo, Vanesa Esteban, Julia Blanco, Sergio Mezzano, Jesús Egido	345
16	Effect of Mycophenolate Mofetil on Kallikrein Expression in the Kidney of 5/6 Nephrectomized Rats 2002 ·Kidney & Blood Pressure Research ·Leopoldo Ardiles, Pamela Ehrenfeld, Yasmir Quiroz, Bernardo Rodríguez‐Iturbe, Jaime Herrera-Acosta, Sergio Mezzano, Carlos D. Figueroa	8
17	Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy 2000 ·Kidney International ·Sergio Mezzano, Alejandra Droguett, M. Eugenia Burgos, Leopoldo Ardiles, C. Aros, I Caorsi, Jesús Egido	114
18	Antibody to streptococcal zymogen in the serum of patients with acute glomerulonephritis: A multicentric study 1998 ·Kidney International ·Gustavo Parra, Bernardo Rodríguez‐Iturbe, Stephen Batsford, Arnold Vogt, Sergio Mezzano, Fernando Olavarría, Ramón Exeni, (unknown), (unknown)	63
19	Study of neoral kinetics in adult renal transplantation treated with diltiazem 1998 ·Transplantation Proceedings ·Sergio Mezzano, Claudio Flores, Leopoldo Ardiles, A Foradori, (unknown)	10
20	Glomerular Localization of Platelet Factor 4 in Streptococcal Nephritis 1992 ·The Nephron journals/Nephron journals ·Sergio Mezzano, (unknown), Leopoldo Ardiles, Fernando Olavarría, Miguel Concha, I Caorsi, Eduardo Aranda, Diego Mezzano	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact